Bioidentical Hormones: What the Term Means—and What It Does Not

Written by Kerri Rachelle, PhD(c), RDN, CSSD, FMP-AC
Founder & CEO, REV0lution | Doctor of Integrative & Natural Medicine Candidate

Quick Answer

A bioidentical hormone has the same molecular structure as the corresponding hormone produced by the human body. Estradiol and micronized progesterone are examples of bioidentical hormones—and both are available in FDA-approved formulations.

“Bioidentical” does not automatically mean compounded, natural, customized, safer or more effective. Compounded preparations may meet legitimate needs when a commercially manufactured product is unsuitable, but customization does not eliminate hormonal risks or guarantee greater precision.

The most useful questions are not simply whether a product is called bioidentical. Women need to know which hormone it contains, how it is manufactured, how it enters the body, how consistently it delivers the intended dose and what evidence supports its use.

Key Takeaways

• Bioidentical describes a hormone’s molecular structure.

• Bioidentical hormone therapy is not synonymous with compounded hormone therapy.

• FDA-approved estradiol and micronized progesterone are bioidentical.

• “Natural” is primarily a marketing term unless its meaning is clearly defined.

• Hormones originating from plant compounds still require substantial laboratory processing.

• Compounded preparations can address legitimate individual needs, but they are not automatically safer or more precise.

• Creams, troches and pellets do not necessarily deliver hormones in the same way as studied patches, gels or capsules.

• Topical progesterone may not reliably protect the uterine lining when systemic estrogen is used.

• Saliva and urine testing cannot determine one permanently perfect hormone dose during perimenopause.

• A bioidentical hormone remains biologically active and can still produce benefits, adverse effects and risks.

What Are Bioidentical Hormones?

Bioidentical hormones are compounds with the same molecular structure as hormones produced by the human body. Estradiol is bioidentical to human estradiol. Micronized progesterone is bioidentical to human progesterone.

That definition does not reveal how a product was manufactured or regulated. It does not tell us whether the dose is consistent, whether the delivery method is appropriate or whether a woman needs the hormone.

The term became confusing when “bioidentical hormone replacement therapy” began being marketed as though it referred exclusively to customized compounded preparations. It does not.

A commercially manufactured estradiol patch and an FDA-approved micronized progesterone capsule are bioidentical. A compounded cream may also contain bioidentical estradiol or progesterone. These products may contain the same hormone molecule while differing in manufacturing, quality testing, delivery and available safety data.

Are Bioidentical Hormones the Same as Compounded Hormones?

No. “Bioidentical” and “compounded” describe two different things.

Bioidentical describes the hormone’s molecular structure. Compounded describes how a specific product is prepared.

Commercially manufactured hormone products may contain bioidentical hormones. A compounding pharmacy may prepare a product using bioidentical hormones, nonbioidentical hormones or a combination of ingredients.

Using the terms interchangeably makes it difficult for women to understand what they are actually receiving. A product can be bioidentical without being compounded, and a compounded product should not be assumed to contain only bioidentical hormones unless its ingredients are clearly identified.

Are Bioidentical Hormones Natural?

Hormones used in therapy may begin with precursor compounds derived from plants such as soy or wild yam. Those compounds must be chemically transformed in a laboratory to create hormones that are molecularly identical to human estradiol or progesterone.

The human body cannot convert an ordinary wild-yam cream into progesterone simply because the plant contains a chemically related precursor.

This processing is not inherently a problem. It is how the intended hormone molecule is created. The concern arises when “plant-derived” or “natural” is used to imply that a product is automatically gentle, harmless or free from the risks associated with hormonal exposure.

A molecule can be bioidentical and powerful. Those facts are not contradictory.

What Is the Difference Between Estrogen and Estradiol?

Estrogen is a category of hormones rather than one substance. The body produces several estrogens, including estradiol, estrone and estriol.

Estradiol is the predominant estrogen during much of a woman’s reproductive life. It is also the bioidentical estrogen most commonly used in systemic menopause hormone therapy. It may be delivered through a patch, gel, spray, oral tablet or compounded preparation.

Conjugated equine estrogens contain a mixture of estrogenic compounds originally derived from pregnant mares’ urine. They are not molecularly identical to human estradiol, but they have been studied extensively and remain approved for specific uses.

“Bioidentical” does not automatically mean effective, appropriate or risk-free. “Nonbioidentical” does not automatically mean ineffective or dangerous. The specific hormone, formulation, route, dose and evidence matter.

What Is the Difference Between Progesterone and Progestin?

Progesterone is a hormone produced naturally after ovulation and during pregnancy. Micronized progesterone is manufactured to be molecularly identical to human progesterone and processed into small particles to improve absorption.

Progestins are synthetic compounds designed to produce effects through progesterone receptors. Medroxyprogesterone acetate, used in the combined-therapy arm of the Women’s Health Initiative, is one example.

Progesterone and individual progestins may differ in their effects, side-effect profiles and clinical evidence. They should not be discussed as though they are identical.

However, identifying a product as progesterone does not tell us how much reaches the bloodstream or uterine lining. An oral capsule, vaginal product and topical cream cannot be assumed to provide equivalent exposure.

What Are Compounded Bioidentical Hormones?

Compounded hormones are prepared by a compounding pharmacy for an individual patient. They may be formulated as creams, capsules, gels, troches, suppositories or implanted pellets. Some products combine several hormones in one preparation.

Compounding has a legitimate role in healthcare. A woman may require a formulation, dose or inactive-ingredient profile that is not commercially available. An allergy or intolerance to an excipient may also create a genuine need.

The distinction is that compounded products do not generally undergo the same product-specific premarket testing, batch standardization, pharmacokinetic evaluation and labeling process required of commercially manufactured medications.

That does not prove that every compounded product is poorly prepared or that every approved product is ideal. It means the amount and type of information available about the finished product may differ.

Women should understand those differences before paying more for a preparation marketed as uniquely natural or personalized.

Does “Customized” Mean More Precise?

Not necessarily.

A compounded prescription can be customized in formulation or dose. That does not prove that it more precisely matches a woman’s physiological needs.

Perimenopausal hormones fluctuate, sometimes substantially, from one day or menstrual cycle to another. One measurement cannot identify a permanently ideal hormone level or prescription.

Customization may be clinically useful when it solves a specific formulation problem. But “customized” should not be confused with “scientifically optimized,” particularly when the dose is based on a single saliva, blood or urine result.

The test used, timing of collection, menstrual pattern, existing hormone use, delivery route, symptoms and treatment goal all affect interpretation.

Can Saliva Testing Determine the Correct Hormone Dose?

Saliva testing can measure hormones present in a sample, but measuring a hormone is not the same as proving that the result identifies the correct therapeutic dose.

Salivary hormone concentrations can be difficult to interpret, particularly when a woman uses topical hormone products. Topical hormones may contaminate the sample or create tissue concentrations that do not correspond predictably with circulating exposure.

Hormonal fluctuations during perimenopause create another limitation. A result from one day may not represent the woman’s exposure throughout the week or menstrual cycle.

Major medical organizations do not recommend using routine salivary hormone testing to calculate compounded hormone doses. The concern is not that the laboratory necessarily failed to detect a hormone. The concern is whether that measurement has been clinically validated for the decision being made.

Can DUTCH Testing Determine the Correct Hormone Dose?

DUTCH testing uses dried urine samples to measure hormones and selected hormone metabolites. Research suggests that dried urine methods can reliably measure certain compounds in the collected sample.

Analytical reliability does not automatically establish diagnostic or dosing validity.

DUTCH testing may provide supplemental information in selected cases when interpreted by a clinician who understands its limitations. It is not a validated stand-alone method for diagnosing perimenopause or determining a uniquely correct hormone prescription.

Results should not override symptoms, menstrual history, medical risk, established diagnostic criteria or appropriate conventional evaluation. Learn more in Functional Medicine Lab Testing: What It Is, What It Isn’t, and When It’s Helpful.

Are Hormone Creams Safer?

Applying a hormone to the skin can alter how it is absorbed and may avoid some first-pass processing through the liver. That does not mean every topical hormone product provides the same exposure.

Commercial estradiol patches and gels undergo testing to evaluate how much hormone they are expected to deliver. A compounded cream may also produce systemic exposure, but the absorbed dose may be less predictable without product-specific pharmacokinetic data.

Progesterone cream requires particular caution. Available evidence has not established that progesterone absorbed through the skin consistently provides the endometrial protection required when a woman with a uterus uses systemic estrogen.

Feeling calmer or sleeping better does not prove that the uterine lining is adequately protected. Symptom response and endometrial protection are two separate outcomes.

What About Hormone Troches?

Troches are designed to dissolve in the mouth, commonly between the cheek and gum or under the tongue. Absorption may occur through oral tissues, while some of the product is swallowed and processed through the digestive system and liver.

This mixed absorption can make hormone exposure more variable than marketing language implies. Troches may be useful in particular circumstances, but they should not automatically be described as more natural, safer or more precise than other routes.

The important questions remain the same: Which hormones are present? What dose is delivered? What evidence supports the formulation? How will clinical response and adverse effects be monitored?

What About Hormone Pellets?

Hormone pellets are implanted beneath the skin and release hormones over time. Some women report substantial symptom improvement, but the delivery method presents practical limitations.

Once inserted, a pellet cannot be adjusted as easily as a patch, gel or oral dose. If exposure is excessive or adverse effects occur, the woman may need to wait for hormone levels to decline. Depending on the dosing practice, pellets may also produce concentrations above typical physiological ranges.

“Long-lasting” can sound convenient, but it also means less immediate control. Cost, dose consistency, expected exposure, adverse effects and the plan for an intolerable dose should be discussed before insertion.

A treatment should not be assumed to be more advanced simply because it is implanted, customized or expensive.

Are Bioidentical Hormones Safer?

The word “bioidentical” cannot answer that question by itself.

Evidence suggests that risks may differ among specific formulations and routes. Transdermal estradiol may have a more favorable blood-clot profile than oral estrogen. Micronized progesterone may differ from certain synthetic progestins in some outcomes. Those distinctions are clinically meaningful.

However, bioidentical hormones can still stimulate breast or endometrial tissue, affect menstrual bleeding, cause breast tenderness, produce headaches or interact with an individual woman’s health risks. Molecular similarity does not erase biological activity.

Safety depends on the hormone, route, dose, duration, uterus status, endometrial protection, age, timing, medical history and other medications—not the marketing category alone.

Does FDA Approval Prove That a Product Is Best for Every Woman?

No. FDA approval indicates that a specific finished product has undergone an established review process for manufacturing, dosing, quality, safety and effectiveness for approved uses.

That information has value, but FDA approval does not make a medication appropriate for every individual, eliminate adverse effects or end scientific debate. Regulatory decisions can also change as evidence and institutional priorities evolve.

Similarly, the absence of FDA approval for an individually compounded product does not automatically prove that it is ineffective or contaminated. It means the finished preparation has not undergone the same product-specific approval process.

Women do not have to choose between blindly trusting a regulator and blindly trusting a customized-hormone marketer. They can ask what evidence applies to the actual product being considered.

Questions to Ask About a Bioidentical Hormone Product

REV0lution does not prescribe or select hormone therapy, but women deserve enough information to have a productive conversation with their prescriber.

Useful questions include:

• What exact hormones are in this product?

• Is each hormone bioidentical, synthetic or part of a mixture?

• Is the finished product commercially manufactured or compounded?

• Why is this route being recommended?

• What symptom or clinical need is the treatment intended to address?

• Is a commercially manufactured version of the same hormone available?

• If compounding is recommended, what specific need does it solve?

• If I have a uterus, how will my endometrium be protected?

• What side effects or bleeding changes should I report?

• How will we determine whether treatment is working?

• How frequently will treatment be reevaluated?

• What is the ongoing cost?

• What happens if I want to reduce or stop treatment?

• If a pellet is recommended, what happens if the dose is too high?

A clinician should be able to explain the treatment without relying on phrases such as “completely natural,” “risk-free,” “perfectly balanced” or “safer because it is customized.”

Where Nutrition and Lifestyle Fit

Women should not be told that real food, exercise and sleep can eliminate every menopausal symptom. Some women maintain excellent health habits and still experience severe night sweats, sleep disruption or vaginal symptoms. Hormone therapy may meaningfully improve their quality of life.

The opposite mistake is treating hormone therapy as though it replaces the foundations of health.

Hormones cannot provide meaningful protein, preserve muscle without resistance training, correct iron deficiency, treat sleep apnea or make regular alcohol exposure metabolically neutral. A woman can feel substantially better while using estradiol or progesterone and still benefit from individualized nutrition, movement, recovery and metabolic care.

This is not about making women earn treatment through perfection. It is about addressing the whole person rather than expecting any single intervention to do every job.

How Can a Dietitian Support You While Using Bioidentical Hormones?

REV0lution helps women strengthen the nutrition, movement and recovery foundation surrounding the treatment plan established by their prescribing clinician. Support may include evaluating protein and total energy intake, preserving muscle through appropriate fueling and resistance training, improving glucose and insulin regulation, correcting nutrient deficiencies, supporting bone health and addressing digestive symptoms.

We can also help create realistic plans for hydration, meal preparation, alcohol reduction and sleep protection while tracking meaningful changes in energy, appetite, sleep, strength, body composition, digestive symptoms and metabolic markers. This information can help women communicate more clearly with their prescribers and understand how the complete plan is affecting their health.

Support should not become another demand for perfection. A woman can benefit from hormone therapy and still have nutrition, sleep or metabolic concerns that deserve attention. The goal is to help the entire plan work together so she can feel, function and perform at her best.

To learn more, read What Is Nutrition Counseling with a Functional Medicine Dietitian?.

The Bottom Line

Bioidentical hormones are real hormones with a specific molecular meaning—not a wellness category.

Estradiol and micronized progesterone are bioidentical and are available in commercially manufactured, FDA-approved formulations. Compounded preparations may also contain bioidentical hormones, but “bioidentical,” “compounded,” “natural,” “customized” and “safer” do not mean the same thing.

A compounded preparation may be appropriate when it meets a need an available commercial product cannot. That does not automatically make it more precise or better monitored. Likewise, FDA approval provides meaningful product-specific information but does not replace independent judgment, informed consent or ongoing evaluation.

Women deserve more than fear-based warnings on one side and expensive hormone marketing on the other. They deserve to know what a product contains, why it is being considered, what is established, what remains uncertain and which questions belong in the conversation with their prescribing clinician.

Medical Disclaimer: This article is for general educational and informational purposes only and does not provide individualized medical or nutrition advice. It is not intended to diagnose, treat, cure, or prevent disease or replace care from a qualified healthcare professional. Do not change your medications, supplements, diet, fasting schedule, or healthcare plan based solely on this content. [Read the full Medical Disclaimer and Terms & Conditions.]

Frequently Asked Questions

What are bioidentical hormones?

Bioidentical hormones have the same molecular structure as corresponding hormones produced by the human body. Estradiol and micronized progesterone are examples. The term describes the hormone molecule—not how the product is manufactured, regulated or delivered.

Are bioidentical hormones the same as compounded hormones?

No. Bioidentical describes molecular structure, while compounded describes how an individual product is prepared. Bioidentical estradiol and micronized progesterone are available in commercially manufactured, FDA-approved formulations as well as in compounded preparations.

Are FDA-approved hormones bioidentical?

Some are. FDA-approved estradiol products and micronized progesterone contain bioidentical hormones. FDA-approved and bioidentical are not opposing categories.

Are bioidentical hormones natural?

Bioidentical hormones may begin with plant-derived precursor compounds, but those compounds undergo laboratory processing to become hormones molecularly identical to human estradiol or progesterone. “Natural” does not mean unprocessed, risk-free or automatically healthier.

Can the body turn wild yam cream into progesterone?

No. Wild yam contains a precursor that can be chemically converted into progesterone in a laboratory, but the human body does not perform that conversion simply because wild-yam cream is applied to the skin.

Are compounded bioidentical hormones safer?

Available evidence has not established that compounded bioidentical hormones are safer or more effective than commercially manufactured hormone products. Compounding may meet a legitimate need involving dose, route or inactive ingredients, but customization does not eliminate hormone-related risks.

Why would someone need a compounded hormone?

Compounding may be useful when a woman needs a dose or delivery form that is not commercially available or cannot tolerate an inactive ingredient in an available product. The prescriber should be able to explain the specific problem the compounded preparation is intended to solve.

Can saliva testing determine the correct hormone dose?

Routine salivary hormone testing has not been validated as a reliable way to calculate an individualized menopause hormone dose. Results may be affected by hormonal fluctuations, collection conditions and topical hormone contamination. Measuring a hormone in saliva does not prove that the result identifies an ideal prescription.

Can a DUTCH test diagnose perimenopause or determine hormone dosing?

DUTCH testing measures urinary hormones and selected hormone metabolites. It may provide supplemental information in selected cases, but it is not a validated stand-alone test for diagnosing perimenopause or calculating a uniquely correct hormone dose. Analytical measurement reliability and clinical dosing validity are different questions.

Is progesterone cream the same as oral micronized progesterone?

No. Route changes absorption and exposure. Progesterone applied to the skin should not be assumed to provide the same systemic or endometrial effects as oral or vaginal micronized progesterone.

Does progesterone cream protect the uterus during estrogen therapy?

Available evidence has not established that transdermal progesterone cream reliably provides adequate endometrial protection when systemic estrogen is used. A woman with a uterus should ask her prescriber exactly how the uterine lining will be protected and monitored.

Are hormone pellets safer or more effective?

Evidence has not established pellets as universally safer or more effective. Once a pellet is inserted, its dose cannot be adjusted as easily as a patch, gel or capsule. Women should ask about expected hormone exposure, adverse effects, monitoring and what happens if the dose is not well tolerated.

Are bioidentical hormones free from cancer and blood-clot risks?

No. A bioidentical hormone remains biologically active. Risk depends on the hormone, formulation, route, dose, duration, whether the woman has a uterus and her personal health history. Molecular similarity does not erase potential effects on breast tissue, the endometrium or clotting.

Does FDA approval prove a hormone is the best option?

No. FDA approval provides product-specific information about manufacturing, dose consistency, quality, safety and effectiveness for approved uses. It does not guarantee that the product is appropriate for every woman or eliminate the need for individualized decision-making.

Can a dietitian help while I am using bioidentical hormones?

Yes. A registered dietitian can help address nutrition, muscle preservation, bone support, glucose regulation, nutrient deficiencies, digestion, hydration, alcohol intake and sleep-supportive habits. Dietitians can also help track symptoms and health markers that improve communication with the prescribing clinician.

References

American College of Obstetricians and Gynecologists. Compounded bioidentical menopausal hormone therapy: ACOG Clinical Consensus No. 6. Obstetrics & Gynecology. 2023;142(5):1266–1273. PMID: 37856860.

The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767–794. PMID: 35797481.

Stanczyk FZ, Bhavnani BR. Bioidentical hormones. Endocrinology and Metabolism Clinics of North America. 2021;50(1):1–15. PMID: 33403887.

Cirigliano M. Bioidentical hormone therapy: a review of the evidence. Journal of Women’s Health. 2007;16(5):600–631. PMID: 17627398.

Fugh-Berman A, Bythrow J. Bioidentical hormones for menopausal hormone therapy: variation on a theme. Journal of General Internal Medicine. 2007;22(7):1030–1034. PMID: 17549577.

Sites CK. Bioidentical hormones for menopausal therapy. Women’s Health. 2008;4(6):593–602. PMID: 19072518.

Conaway E. Bioidentical hormones: an evidence-based review for primary care providers. Journal of the American Osteopathic Association. 2011;111(3):153–164. PMID: 21464264.

Stanczyk FZ. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause. 2005;12(2):232–237. PMID: 15772572.

Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric. 2000;3(3):155–160. PMID: 11910616.

Stanczyk FZ, Paulson RJ, Roy S. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause. 2005;12(2):232–237. PMID: 15772572.

Stute P, Neulen J, Wildt L. The impact of micronized progesterone on the endometrium: a systematic review. Climacteric. 2016;19(4):316–328. PMID: 27277331.

Newman M, Pratt SM, Curran DA, Stanczyk FZ. Reliability of a dried urine test for comprehensive assessment of urine hormones and metabolites. BMC Chemistry. 2021;15(1):18. PMID: 33722278.

Goldštajn MŠ, Mikuš M, Ferrari FA, et al. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review. Archives of Gynecology and Obstetrics. 2023;307(6):1727–1745. PMID: 35713694.

Abenhaim HA, Suissa S, Azoulay L, Spence AR, Czuzoj-Shulman N, Tulandi T. Menopausal hormone therapy formulation and breast cancer risk. Obstetrics & Gynecology. 2022;140(1):110–122. PMID: 35675607.

Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes & Endocrinology. 2019;7(10):754–766. PMID: 31353194.